Robert W. Baird initiated coverage on shares of Vaxxinity (NASDAQ:VAXX – Free Report) in a report issued on Thursday morning, Marketbeat reports. The brokerage issued an outperform rating and a $7.00 target price on the stock. Vaxxinity Price Performance Shares of Vaxxinity stock opened at $1.71 on Thursday. The company has a debt-to-equity ratio of […]